INTRODUCTION
Periodontal disease is a multifactorial disease of the supporting tissues of the teeth. This disease has a relative high prevalence in the population, and is the leading cause of tooth loss (Zhong et al., 2012) . Periodontitis can occur when there is an imbalance between periodontopathogenic bacterial species and the host's defense, which is characterized by exacerbation of inflammatory and immunological reactions against the bacterial biofilm ( Andrade et al., 2013) . Many studies have attempted to identify genetic polymorphisms in mediators of the immune response, such as those that have been considered to be potential susceptibility factors related to periodontal disease (Kornman et al., 1997; Moreira et al., 2007; Tervonen et al., 2007) .
The gene encoding for interleukin (IL)-10 is mapped on chromosome 1q31-q32, in a cluster with closely related interleukin genes, including . Several promoter polymorphisms have been described in the IL-10 gene including the single nucleotide polymorphisms (SNPs) at positions -1082 (G/A), which occurs within a putative E26 transformationspecific transcription factor-binding site (Kim et al.,1992) . This cytokine may act on different cell types, by supressing the anti-inflammatory response in various tissues. Moreover, IL-10 is thought to be the main molecule responsible for the response to inflammatory reactions, particularly to inhibit changes mediated by tumor necrosis factor-α (Cullinan et al., 2008; Begue et al., 2011) . Its action inhibits the synthesis of proinflammatory cytokines and stimulates the proliferation and differentiation of cells specialized in the body's defense (Begue et al., 2011) . IL-10 is also thought to play a role in periodontitis by downregulating the production of monocyte derived proinflammatory cytokines and stimulating protective antibody production (Rousset et al., 1992; de Waal Malefyt et al., 1993) . As a result, IL-10 is very important in the immunopathogenesis of chronic inflammatory diseases, such as periodontal disease (Gemmell et al., 1997; Okada and Murakami, 1998) . The aim of this study was evaluate the SNP -1082G/A in the promoter region of the IL-10 gene and its relation with the periodontal disease in Central Brazilian individuals.
MATERIAL AND METHODS

Sample population
This study included 66 adult Brazilian individuals who lived in the city of Goiânia. The group was divided into 36 cases and 30 controls, grouped in ages ranging from 30-55 years and divided into 5-year periods. Cases were defined as individuals of both genders diagnosed with periodontal disease, regardless of its severity (mild, moderate or severe) clinically identified during physical examination with a millimiter periodontal probe, known as a Michigan O probe (Hu-Friedy, Chicago, IL, USA), with markings of 3, 6, and 8 mm. Controls included healthy individuals, that did not present during the physical examination any clinical signs of periodontal disease with the same distribution by age and gender.
Subjects were instructed as to the character and purpose of the study, and all subjects signed an informed consent. The study protocol was reviewed and approved by the Ethics Committee on Human Research at the Pontifical Catholic University of Goiás under the protocol number 1721/204.
Biological samples and genotyping identification
In order to identify the polymorphism -1082G/A of IL-101, biological samples were obtained by collecting 5 mL peripheral blood in EDTA. Genomic DNA was isolated from whole blood using an Invisorb ® Spin Blood Mini kit (Invitec Düsseldorfer Landstraße, Germany) according to the manufacturer instructions and stored at -70°C until further processing.
Genotyping was performed by amplification refractory mutation system polymerase chain reaction (ARMS-PCR) (Mellati et al., 2007) . Amplification reactions were prepared in a final volume of 50 μL containing approximately 100 ng DNA, 7 μL Gold STR 10X ® Buffer (Promega Corporation, Madison, WI, USA), 2 μL 50 mM MgCl 2 , 5 U Taq DNA polymerase (Promega Corporation) and a 1-μL solution containing the A or G sense primers, generic antisense primer, and internal control primers 1 and 2.
The amplicons produced corresponded to fragments of approximately 258 bp. Primers for the internal control of reaction corresponded to an amplicon length of 429 bp of the human growth hormone sequence (Perrey et al., 1999) .
The sequences of the primers used in the ARMS-PCR were: generic primer: 5'-CAGTGCCAACTGAGAATTTGG-3', primer A: 5'-ACT ACT AAG GCT TCT TTG GGA A-3', primer G: 5'-CTA CTA AGG CTT CTT TGG GAG-3', internal control primer 1: 5'-GCC TTC CCA ACC ATT CCC TTA-3', and internal control primer 2: 5'-TCA CGG ATT TCT GTT GTG TTT C-3'.
ARMS-PCR was performed using the DNA thermocycler IQ5 ® (Bio-Rad, Hercules, CA, USA). Amplicons were obtained using an initial denaturation of 95°C for 1 min followed by 10 cycles of denaturation at 95°C for 15 s, annealing at 65°C for 50 s and extension at 72°C for 40 s with the A primers, generic primer and internal control primers. Then, 20 cycles were performed for the amplification of primer B at 95°C for 20 s, annealing at 59°C for 20 s and extension at 72°C for 20 s. In both thermocycling protocols it was used an extension final step at 72°C for 5 min.
The amplicons were visualized by 2% agarose gel electrophoresis, submitted to an electric field of 10 V/cm, for one and a half hour. As molecular weight marker, it was used the 100-bp DNA ladder (Invitrogen, USA). The ARMS-PCR products were stained with ethidium bromide 0.5 mg/ IL-10 polymorphism and chronic periodontal disease in adults ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 14 (4): 17828-17833 (2015) mL and documented using the Video Documentation System (VDS ® , Amersham Bioscience, USA), connected to a microcomputer with a capture system and analysis of 21 images (Imagemaster ® , Amersham Bioscience, USA).
Statistical analysis
In order to verify the Hardy-Weinberg balance and the expected and observed heterozygosity in the patients from the case group and the control group it was used the Arlequin Program (versão 3.4) (Schneider et al., 2000) . It was used an indirect estimator of relative risk (odds ratio), for the search of exposure factors, the genotypic frequencies found in the case group and in the control group were compared. The linear regression test (16) , was used to correlate the severity of the periodontal disease and the IL-10 genotype, in the distribution of genotypes of IL-10 in different age groups in the sample group. Significance level was set at P < 0.05.
RESULTS
Of the 36 patients analyzed in the case group, 24 (67%) were males and 12 (33%) were females. The mean age of patients was 43 ± 7.3 years. The genotypes of the case and control groups after molecular analysis were classified as AA, AG and GG, in the locus of the IL-10 gene. In the control group, 13 (43%) individuals had the AG genotype, 12 (40%) had GG and only 5 (17%) had AA. The genotype frequencies of case and control groups were compared by the χ 2 test, but statistically significant differences were not detected (P = 0.96) for the distribution of these frequencies. The frequencies of alleles A and G were also compared by the χ 2 test between the case and control groups, but the differences were not statistically significant (P = 0.92).
After analysis of the odds ratio, because the lower extreme of the confidence intervals did not exceed 1 and the odds ratio rates were approximately equal to 1, the 3 genotypes of IL-10 were likely not related to periodontal disease in the groups of individuals in this study.
Patients selected for the case group in this study had periodontal disease in degrees classified as mild, moderate and severe. In the age group of 30-35 years, 5 (71%) patients had mild periodontitis and 2 (29%) had severe condition. In the 35-40 group, 5 (71%) had moderate periodontal disease. However, in the age group of 40-50 years, there was a higher prevalence of mild disease, occurring in 100% of patients aged 40-45 years and 62.5% of patients aged 45-50 years. Finally, in the group of 50-55 years, 4 (75%) patients presented moderate periodontal disease. Analysis of patients with periodontal disease revealed that 22 (61%) had mild periodontitis, 9 (25%) had moderate periodontitis and 5 (14%) had severe periodontitis.
The distribution by gender and its relationship with the severity of periodontal disease showed that of women, 8 (67%) had mild periodontitis, 3 (25%) had moderate periodontitis and only 1 patient (8%) had severe periodontitis. In men, 14 (58%) had mild periodontitis, 6 (25%) had moderate periodontitis, and 4 (16%) had severe periodontitis. In this case, men were 2-fold more likely to present the severe form of the disease compared to women (16 vs 8%, respectively).
The genotype distribution of IL-10 was also associated with the degree of severity of periodontal disease. In the analysis of the group of patients with the mild form, 6 (27%) cases had the genotype AA, 4 (50%) had the genotype AG and 5 (23%) had the genotype GG. In its moderate form, the genotype AG, was the most prevalent and was detected in 6 (67%) cases. In the severe form of the condition, the genotype AG was found in only 1 (20%) case.
The linear regression test showed that the severity of periodontal disease was not associated with the distribution of genotypes of IL-10 (P = 0.61), in the different age groups in the sample group.
DISCUSSION
In periodontitis, the high variability of cytokine levels and the low frequency of this detection may contribute to the presence and/or severity of the disease (Atanasovska-Stojanovska et al., 2012 ). In the current study, the SNP -1082G/A located in the promoter region of IL-10 in patients with periodontal disease and controls was evaluated. The analysis of the frequency of genotypes and allele frequencies revealed no causal relationship between the presence of genotype G or A and the development of periodontal disease in adults.
The most severe cases were observed in subjects greater than 45 years of age, while milder cases were observed in younger age groups. However, no association between the occurrence of the SNP -1082G0/A and periodontal disease was identified. Although more cases were observed among men, no statistically significant association was found in the distribution of genotypes and disease severity in this group. In the present study, the lack of statistical significance in the linear regression test showed that the SNP -1082G/A of the IL-10 gene has no predictive value for periodontal disease. However, the authors reported a higher frequency of the genotype GG in individuals with periodontitis, suggesting that the G allele plays an important role in the course of periodontal disease (Scarel-Caminaga et al., 2004; Moreira et al., 2007; Tervonen et al., 2007) .
Regarding the severity of the disease, we did not observe a higher frequency of the genotype GG in the sick patients. Moreover, the findings of this study are in agreement with those of Kinane and Hard (2003) and Yamazaki et al. (2001) , who found no association between the SNP -1082G/A and the occurrence and/or severity of periodontal disease. A large number of studies have found that proinflammatory cytokines are related to the pathogenesis and progression of periodontal disease, thus interventions with the manipulation of anti-inflammatory cytokines have been suggested as adjuvants for treating periodontal disease. However, despite this therapeutic potential, the role of IL-10 in the progression of the periodontal disease has not been thoroughly examined.
The genetic profile of periodontal disease is not well understood. Previous studies suggest a strong association between disease occurrence and individual genetic makeup (Kornman et al., 1997; Folwaczny et al., 2004; Droździk et al., 2006; Mellati et al., 2007) . However, this association has not been thoroughly examined (Gasche et al., 2003) . Studies of the potential relationship between periodontal disease genetic factors may lead to point to the development of better methods for diagnostics.
CONCLUSIONS
The results of this study indicate that SNP -1082G/A in the IL-10 gene is not involved in the development of periodontal disease. The genetic polymorphism must be further evaluated before it can be used as a diagnostic marker of periodontal disease in adults. In addition, the IL-10 polymorphism showed no prognostic value, which may help healthcare professionals to choose the best course of treatment. The choice of therapy should be based not only on periodontal destruction presented, but also on the risk of developing more severe periodontal problems.
